Medikit Co.,Ltd.
7749.TJPXHealthcareMedical - Instruments & Supplies
Latest quote
¥2,890
+¥29.00 · +1.01%
7749.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteEstablished in Tokyo, Japan, in 1973, Medikit Co.,Ltd. specializes in the development, manufacturing, and global distribution of advanced medical devices for vascular access. Their comprehensive product portfolio encompasses various intravenous (IV) catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V. They further provide solutions for hemodialysis, including Supercath PRO, Supercath NEO, and Supercath Clampcath, alongside interventional products like Supersheath and Mongoose. These critical medical instruments find application in diverse healthcare settings, notably in anesthesiology departments, operating theaters, intensive care units (ICUs), and within both dialysis and cardiology facilities. Medikit Co.,Ltd. expands its market reach by leveraging a network of distributors, serving approximately 20 countries and territories throughout the European Union and the Americas.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Hiroaki Nakajima
- Listed since
- Jun 28, 2005
- Employees
- 994
Market position
Day range
Current ¥2,890
52-week range
Current ¥2,890
- Open
- ¥2,861
- Previous close
- ¥2,861
- Volume
- 1.2K
- 0.75× average
- Average volume
- 1.59K
- Average daily volume
- Market cap
- 41.84B JPY
- Beta
- 0.09
- Market reference 1
- 50-day average
- ¥2,812.3
- +2.76% above average
- 200-day average
- ¥2,905.02
- -0.52% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 24.93B JPY
- P/E (TTM)
- 13.4×
- P/B (TTM)
- 0.9×
- P/S (TTM)
- 1.72×
- EV / EBITDA
- 3.95×
- Earnings yield
- 6.90%
- Free cash flow yield
- 2.97%
- Dividend yield
- 3.46%
Profitability & efficiency
- Gross margin
- 35.77%
- Operating margin
- 18.61%
- Net margin
- 12.93%
- Return on equity
- 6.43%
- Return on assets
- 5.64%
- Return on invested capital
- 5.93%
Financial health
- Debt / equity
- 0×
- Current ratio
- 6.25×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 23.78B JPY | 22.55B JPY | 21.85B JPY | 21.61B JPY | 20.13B JPY |
| Cost of goods sold | 15.34B JPY | 14.22B JPY | 13.43B JPY | 13.56B JPY | 12.19B JPY |
| Gross profit | 8.44B JPY | 8.33B JPY | 8.42B JPY | 8.05B JPY | 7.95B JPY |
| Research and development | 299.35M JPY | 271.55M JPY | 278.44M JPY | 323.09M JPY | 327.96M JPY |
| Selling, general, and administrative | 3.87B JPY | 3.57B JPY | 3.47B JPY | 3.61B JPY | 3.2B JPY |
| Operating expenses | 4.17B JPY | 3.85B JPY | 3.75B JPY | 3.93B JPY | 3.53B JPY |
| Interest income | 46.39M JPY | 15.45M JPY | 4.39M JPY | 3.38M JPY | 2.72M JPY |
| Interest expense | 7.67M JPY | — | — | — | 7.36M JPY |
| Depreciation and amortization | 2.04B JPY | 1.69B JPY | 1.54B JPY | 1.32B JPY | 1.27B JPY |
| Operating income | 4.27B JPY | 4.49B JPY | 4.67B JPY | 4.11B JPY | 4.42B JPY |
| Net income | 3.01B JPY | 3.01B JPY | 3.07B JPY | 2.86B JPY | 2.99B JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 36.15
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Mar 30, 2020 | 2:1 | — | — |
Stock split | Sep 26, 2012 | 10:1 | — | — |
Stock split | May 26, 2006 | 2:1 | — | — |
Effective Mar 30, 2020
2:1
Effective Sep 26, 2012
10:1
Effective May 26, 2006
2:1
7749.T peers
ETFs holding 7749.T
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 7749.Tresearch.disclaimer